Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid Cancer

The goal of this study is to learn if a decision aid (DA) website helps people with thyroid cancer make informed decisions about radioactive iodine (RAI) treatment. The main questions it aims to answer are: - Does the decision aid help participants understand the risks and benefits of RAI treatment? - Does it help participants make choices that reflect what matters most to them? - How does the decision aid compare to usual care in supporting patients through this decision? Participants who have been recently diagnosed with intermediate-risk differentiated thyroid cancer (DTC) will be randomly

Trial Details

NCT ID
NCT06980103
Phase
NA
Sponsor
Georgetown University
Status
RECRUITING
Cancer Type
Thyroid Cancer
Interventions
  • Decision Aid
  • Usual Care
Locations (sample)
  • Washington D.C., District of Columbia, United States|38.89511,-77.03637
  • Washington D.C., District of Columbia, United States|38.89511,-77.03637
  • Falls Church, Virginia, United States|38.88233,-77.17109

Key Eligibility Criteria

  • Patients aged 18 and older
  • Patients diagnosed with intermediate risk DTC \< 6 months ago and who are making a decision about RAI treatment
  • Ability to understand the information conveyed in the informed consent form, pose questions and process answers (e.g., no cognitive impairment per …
  • Participants willingness to be contacted and remain available to complete study activities throughout the duration of the study.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Thyroid Cancer Trials on Trialify →